Cargando…
Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID‐19: Derivation and Validation of the HA(2)T(2) COVID‐19 Mortality Risk Score
BACKGROUND: The independent prognostic value of troponin and other biomarker elevation among patients with coronavirus disease 2019 (COVID‐19) are unclear. We sought to characterize biomarker levels in patients hospitalized with COVID‐19 and develop and validate a mortality risk score. METHODS AND R...
Autores principales: | Manocha, Kevin K., Kirzner, Jared, Ying, Xiaohan, Yeo, Ilhwan, Peltzer, Bradley, Ang, Bryan, Li, Han A., Lerman, Bruce B., Safford, Monika M., Goyal, Parag, Cheung, Jim W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174190/ https://www.ncbi.nlm.nih.gov/pubmed/33121304 http://dx.doi.org/10.1161/JAHA.120.018477 |
Ejemplares similares
-
Arrhythmic Complications of Patients Hospitalized With COVID-19: Incidence, Risk Factors, and Outcomes
por: Peltzer, Bradley, et al.
Publicado: (2020) -
HaNDL syndrome after COVID-19
por: García, J.C.N., et al.
Publicado: (2022) -
Conflict in troponin levels in COVID-19 patients
por: Turgay Yıldırım, Özge, et al.
Publicado: (2021) -
COVID-19, cardiovascular diseases and cardiac troponins
por: Kim, Chan W, et al.
Publicado: (2021) -
TROPONIN CORRELATES WITH INFLAMMATORY MARKERS IN COVID-19
por: Klinkhammer, Brent, et al.
Publicado: (2021)